Results 151 to 160 of about 13,196 (266)
Medicinal Research Reviews, Volume 46, Issue 3, Page 672-712, May 2026.ABSTRACT Respiratory syncytial virus (RSV) is a common virus that causes respiratory infections, posing a serious threat, particularly to infants, the elderly, and individuals with compromised immune systems. As the leading cause of lower respiratory tract infections (LRTIs) in infants, RSV is responsible for millions of cases worldwide each year.
Jie Shi +6 more
wiley +1 more source
What Is Your Diagnosis? Submandibular Mass in a Dog
Veterinary Clinical Pathology, EarlyView.
Whitney K. Chandler +3 more
wiley +1 more source
Procedural‐Based Contemporary Management of Bell's Palsy Long‐Term Sequelae: A Narrative Review
Otolaryngology–Head and Neck Surgery, Volume 174, Issue 5, Page 1177-1187, May 2026.Abstract Objective To describe the long‐term sequelae of Bell's palsy and summarize available treatment options, including recent advances, so that general otolaryngologists and other practitioners are aware of the clinical findings and available interventions. Data Sources PubMed.
Robert M. Frederick +3 more
wiley +1 more source
Congenital aniridia: European COST action ANIRIDIA‐NET guidelines for diagnosis, management and care
Acta Ophthalmologica, Volume 104, Issue 3, Page 267-279, May 2026.Abstract Congenital aniridia is a rare ocular disorder affecting the majority of eye structures and can be associated with systemic manifestations. The main visible phenotypic characteristic is the partial or complete absence of the iris; however, foveal hypoplasia is a more frequent and reliable clinical sign. Other ocular comorbidities are associated
Davide Romano +26 more
wiley +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Eyelid neoplasms: Case reports [La patologia neoplastica palpebrale nella nostra esperienza
, 2001 The authors review the clinical peculiarity of the eyelid neoplasms, they report the frequency, the seat and statistical delivery of 154 personal cases; they describe for every case the surgical therapy, traditional and modern, and laser surgery.
LANZA, Michele +3 more
openaire +4 more sources
Therapeutic potential of mesenchymal stem cells in peripheral nerve injuries in horses
Equine Veterinary Education, Volume 38, Issue 5, Page 252-260, May 2026.Summary Peripheral nerve injuries (PNI) in horses represent a significant clinical challenge, frequently associated with functional deficits and reduced athletic performance. Conventional therapeutic approaches, primarily based on anti‐inflammatory treatments and rehabilitation, offer limited efficacy, driving the search for innovative alternatives. In
L. V. de Oliveira Ferreira +1 more
wiley +1 more source
Recurrent Cutaneous Myxoma of the Eyelid: A Case Report. [PDF]
Case Rep Ophthalmol MedFonseca MI +3 more
europepmc +1 more source
Multiple Periocular Eccrine Hidrocystomas Mimicking Malignancy: A Clinicopathologic Diagnostic Challenge. [PDF]
CureusRoa Alvarez G +6 more
europepmc +1 more source
Breaking Down Barriers: CorA Effectively Targets Staphylococcal Biofilms in Vitro and in Vivo
ChemMedChem, Volume 21, Issue 7, 14 April 2026.Corallopyronin A (CorA), a natural alpha‐pyrone antibiotic, penetrates Staphylococcus aureus biofilms and inhibits RNA polymerase. This work demonstrates CorA's superior efficacy compared to rifampicin and dalbavancin in reducing viable loads in biofilms both in vitro and in vivo. Graphic created in https://BioRender.com.
Stefania De Benedetti +21 more
wiley +1 more source